26.03.21
Benzinga
When the COVID-19 pandemic hit the world by surprise last year, cannabis businesses around the world faced the uncertainty of one of the most challenging years for everyone.
26.03.21
Yahoo Finance
When the COVID-19 pandemic hit the world by surprise last year, cannabis businesses around the world faced the uncertainty of one of the most challenging years for everyone.
25.03.21
Fanack
Morocco approved in March 2021 a law that will see a legal cannabis industry emerge in one of the highest marijuana producing countries in the world. The move could bring significant benefits to Morocco but challenges remain for farmers who make most of their income from the resin that will linger in the informal and illegal economy.
22.03.21
Benzinga
SOMAÍ Pharmaceuticals Ltd. co-founder and CEO Michael Sassano recently spoke to Benzinga about a particular value buy that’s piqued his interest.
He also touched on recent market fluctuations, the global marketplace’s development and what it means to investors.
22.03.21
Cannabis Industry Journal
The unusual nature of 2020 gave rise to a reciprocally roller-coaster-like cannabis market. Cannabis was cemented officially as an essential industry with the rise of COVID-19, and November elections resulted in even more United States markets welcoming medical and adult-use sales.
22.03.21
Cannabis Business Executive
If you’re reading this you undoubtedly know that special purpose acquisition companies (SPACs) are all the rage. So, let’s talk about the future of raising money in cannabis.
18.03.21
Cannabis Law Report
In the quest to become GMP compliant, design and flow of your manufacturing facility are critical. Mistakes in the design phase will cost money and eventual time loss, so taking this step seriously and planning to the end for every detail must be a top priority.
26.02.21
Benzinga Capital Conference
Michael Sassano, CEO of Somai Pharmaceuticals talk about the European Cannabis Market and how it is starting to look like the USA 10 years ago
25.02.21
Cannabis Business Executive
Despite Europe’s unification, each country is still making their own rules on providing access to medical cannabis for patients. Currently there are 14 countries in Europe that recognize cannabis products for medical sales.